Gary M. Winer

Insider Reports History

Reporting-owner location: Orlando, FL
Latest reporting-owner signature: /s/ Nicholas T. Curtis, attorney-in-fact
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Gary M. Winer

Form 4 holding Director

LENSAR, Inc.

Security class: Common Stock
Shares / value: 105,635
Estimated value: $629,584
Report date: 03 Jun 2026
Price: $5.96
Ownership: Direct

Form 4 holding Director

HCW Biologics Inc.

Security class: Common Stock
Shares / value: 4,075
Estimated value: $30,358
Report date: 16 May 2025
Price: $7.45
Ownership: Direct

Form 4 holding Director

HCW Biologics Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 12,500
Estimated value
Report date: 14 Jun 2024
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

HCW Biologics Inc.

Security class: Common Stock Purchase Warrant
Shares / value: 1,154
Estimated value
Report date: 07 May 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Gary M. Winer

4 LNSR

LENSAR, Inc.

Report period: 03 Jun 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 05 Jun 2026, 17:30
Role: Director
Next action: Open filing details

4 LNSR

LENSAR, Inc.

Report period: 23 May 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 28 May 2025, 16:30
Role: Director
Next action: Open filing details

4 HCWB

HCW Biologics Inc.

Report period: 16 May 2025
Transactions: 1
Transaction value: +$9,998
Accepted by SEC: 20 May 2025, 16:35
Role: Director
Next action: Open filing details

4 HCWB

HCW Biologics Inc.

Report period: 07 May 2025
Transactions: 2
Transaction value: +$60,008
Accepted by SEC: 09 May 2025, 17:33
Role: Director
Next action: Open filing details

4 LNSR

LENSAR, Inc.

Report period: 03 Sep 2024
Transactions: 1
Transaction value: +$3,082
Accepted by SEC: 06 Sep 2024, 09:00
Role: Director
Next action: Open filing details

4 LNSR

LENSAR, Inc.

Report period: 26 Aug 2024
Transactions: 3
Transaction value: +$10,373
Accepted by SEC: 29 Aug 2024, 06:05
Role: Director
Next action: Open filing details

4 LNSR

LENSAR, Inc.

Report period: 21 Aug 2024
Transactions: 2
Transaction value: +$2,185
Accepted by SEC: 23 Aug 2024, 18:52
Role: Director
Next action: Open filing details

4 LNSR

LENSAR, Inc.

Report period: 16 Aug 2024
Transactions: 2
Transaction value: +$2,124
Accepted by SEC: 20 Aug 2024, 17:24
Role: Director
Next action: Open filing details

4 LNSR

LENSAR, Inc.

Report period: 12 Aug 2024
Transactions: 2
Transaction value: +$6,215
Accepted by SEC: 14 Aug 2024, 20:31
Role: Director
Next action: Open filing details

4 HCWB

HCW Biologics Inc.

Report period: 14 Jun 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 17 Jun 2024, 16:56
Role: Director
Next action: Open filing details

4 LNSR

LENSAR, Inc.

Report period: 07 May 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 09 May 2024, 16:31
Role: Director
Next action: Open filing details

4 LNSR

LENSAR, Inc.

Report period: 22 Nov 2023
Transactions: 1
Transaction value: +$630
Accepted by SEC: 27 Nov 2023, 19:30
Role: Director
Next action: Open filing details

4 LNSR

LENSAR, Inc.

Report period: 15 Nov 2023
Transactions: 2
Transaction value: +$3,200
Accepted by SEC: 17 Nov 2023, 18:18
Role: Director
Next action: Open filing details

4 LNSR

LENSAR, Inc.

Report period: 10 Nov 2023
Transactions: 1
Transaction value: +$2,135
Accepted by SEC: 14 Nov 2023, 19:31
Role: Director
Next action: Open filing details

4 HCWB

HCW Biologics Inc.

Report period: 13 Sep 2023
Transactions: 4
Transaction value: +$3,256
Accepted by SEC: 15 Sep 2023, 18:53
Role: Director
Next action: Open filing details

4 HCWB

HCW Biologics Inc.

Report period: 08 Sep 2023
Transactions: 3
Transaction value: +$1,230
Accepted by SEC: 12 Sep 2023, 20:40
Role: Director
Next action: Open filing details

4 HCWB

HCW Biologics Inc.

Report period: 05 Sep 2023
Transactions: 2
Transaction value: +$823
Accepted by SEC: 07 Sep 2023, 16:48
Role: Director
Next action: Open filing details

4 LNSR

LENSAR, Inc.

Report period: 10 Aug 2023
Transactions: 2
Transaction value: +$6,198
Accepted by SEC: 14 Aug 2023, 19:01
Role: Director
Next action: Open filing details

4 HCWB

HCW Biologics Inc.

Report period: 13 Jun 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 15 Jun 2023, 17:16
Role: Director
Next action: Open filing details

4 HCWB

HCW Biologics Inc.

Report period: 30 May 2023
Transactions: 2
Transaction value: +$2,043
Accepted by SEC: 01 Jun 2023, 17:29
Role: Director
Next action: Open filing details

4 LNSR

LENSAR, Inc.

Report period: 25 May 2023
Transactions: 2
Transaction value: $0
Accepted by SEC: 30 May 2023, 16:58
Role: Director
Next action: Open filing details

4 LNSR

LENSAR, Inc.

Report period: 22 Nov 2022
Transactions: 2
Transaction value: +$9,000
Accepted by SEC: 23 Nov 2022, 15:46
Role: Director
Next action: Open filing details

4 LNSR

LENSAR, Inc.

Report period: 16 Nov 2022
Transactions: 2
Transaction value: +$10,400
Accepted by SEC: 17 Nov 2022, 17:09
Role: Director
Next action: Open filing details

4 LNSR

LENSAR, Inc.

Report period: 17 Aug 2022
Transactions: 3
Transaction value: +$30,150
Accepted by SEC: 22 Aug 2022, 16:57
Role: Director
Next action: Open filing details

4 HCWB

HCW Biologics Inc.

Report period: 15 Jun 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 17 Jun 2022, 16:21
Role: Director
Next action: Open filing details

4 HCWB

HCW Biologics Inc.

Report period: 08 Jun 2022
Transactions: 3
Transaction value: +$7,673
Accepted by SEC: 10 Jun 2022, 20:03
Role: Director
Next action: Open filing details

4 HCWB

HCW Biologics Inc.

Report period: 06 Jun 2022
Transactions: 2
Transaction value: +$4,227
Accepted by SEC: 08 Jun 2022, 16:45
Role: Director
Next action: Open filing details

4 LNSR

LENSAR, Inc.

Report period: 25 May 2022
Transactions: 2
Transaction value: $0
Accepted by SEC: 27 May 2022, 20:01
Role: Director
Next action: Open filing details

4/A HCWB

HCW Biologics Inc.

Report period: 26 Oct 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 28 Oct 2021, 20:14
Role: Director
Next action: Open filing details

3 HCWB

HCW Biologics Inc.

Report period: 26 Oct 2021
Transactions: 0
Transaction value: $0
Accepted by SEC: 28 Oct 2021, 17:05
Role: Director
Next action: Open filing details

4 LNSR

LENSAR, Inc.

Report period: 18 May 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 20 May 2021, 16:15
Role: Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .